MedTrace Logo

Effectiveness of Stereotactic RadioTherapy in Solid Primary Inoperable and Oligometastatic Cancer

NCT03461822 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2018-03-12

No results posted yet for this study

Summary

The purpose of this study is to development of more effective treatment tactics of the stereotactic radiotherapy and radiosurgery alone and together with classic radiation therapy in primary inoperabel solid tumors and oligometastastatic cancer.

Conditions

  • Radiotherapy

Sponsors & Collaborators

  • The National Center of Oncology, Azerbaijan

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2019-12-31
Completion
2020-01-31

Countries

  • Azerbaijan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03461822 on ClinicalTrials.gov